SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Transgene Biotek reports Profit after tax of Rs -25.16 Mln, in the December 2020 quarter

23 Jan 2021 Evaluate
A slight decline in the revenue of Rs. 1.57 millions was seen for the December 2020 quarter as against Rs. 0.00 millions during year-ago period.The Net Loss for the quarter ended December 2020 is Rs. -25.16 millions as compared to Net Loss of Rs. -26.61 millions of corresponding quarter ended December 2019 Operating profit Margin for the quarter ended December 2020 improved to 0.32% as compared to -1.12% of corresponding quarter ended December 2019


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202012 201912 % Var 202012 201912 % Var 202003 201903 % Var
Sales 1.57 0.00 0.00 1.57 0.00 0.00 0.04 0.71 -94.37
Other Income 0.51 0.44 15.91 1.39 1.39 0.00 1.79 20.38 -91.22
PBIDT 0.32 -1.12 -128.57 -1.96 -4.48 -56.25 -6.84 13.52 -150.59
Interest 0.67 0.75 -10.67 1.99 3.05 -34.75 3.81 2.51 51.79
PBDT -0.35 -1.87 -81.28 -3.95 -7.53 -47.54 -10.65 11.01 -196.73
Depreciation 24.81 24.74 0.28 74.29 74.22 0.09 98.97 98.94 0.03
PBT -25.16 -26.61 -5.45 -78.24 -81.75 -4.29 -109.62 -87.93 24.67
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -25.16 -26.61 -5.45 -78.24 -81.75 -4.29 -109.62 -87.93 24.67
Equity 757.70 757.70 0.00 757.70 757.70 0.00 757.70 757.70 0.00
PBIDTM(%) 20.38 0.00 0.00 -124.84 0.00 0.00 -17100.00 1904.23 -998.00

Transgene Biotek Share Price

3.10 0.22 (7.64%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 435.70
Indegene 486.80
CMS Info Systems 318.00
JITF Infralogistics 338.00
Sagility 42.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×